Stay updated on NC410 Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updates the page’s displayed software/version identifier from **Revision: v3.5.2** to **Revision: v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:41.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T13:30:12.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added and the previous v3.4.3 entry was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-19T19:19:45.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added and the previous revision v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-12T10:40:00.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    New revision entry v3.4.2 was added, and a government funding notice and the earlier revision entry v3.4.1 were removed from the history log. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T20:33:08.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A new site-wide notice about government funding has been added and the revision indicator updated from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-04T10:53:14.000Z thumbnail image

Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.